Meeting
2023 ASCO Genitourinary Cancers Symposium
Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI).
Authors
Anna Couvillon
National Cancer Institute, National Institutes of Health, Bethesda, MD
Anna Couvillon , Baris Turkbey , Peter L. Choyke , Katherine Lee-Wisdom , Yolanda McKinney , Robert Sidlow , Michael P. Mullane , Veda N. Giri , Todd Matthew Morgan , Heather H. Cheng , Maria J. Merino , William Douglas Figg , Peter A. Pinto , William L. Dahut , Fatima Karzai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Other
Clinical Trial Registration Number
NCT03805919
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 390)
DOI
10.1200/JCO.2023.41.6_suppl.390
Abstract #
390
Poster Bd #
P7
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller
Poster
2023 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller
Poster
2019 ASCO Annual Meeting
Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative.
First Author: Allison W. Kurian
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos